Publication | Open Access
Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States
33
Citations
19
References
2020
Year
Adherence and persistence are significantly improved with ADA-CF compared with ADA-C.
| Year | Citations | |
|---|---|---|
Page 1
Page 1